Work

Occurrence of Rapid Early Progression (REP) and Rapid Early Response (RER) in Patients with Newly Diagnosed GBM Undergoing Resection and Immediate Post Resection Brachytherapy: A Preliminary Report from a Prospective Multicenter Trial

Year: 2024

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.07.611

Authors: L. Sloan, C. Chen, C. Ferreira, E. Neil, D.J. McCracken, J. Wanebo, K. Smith, O. Bloch, M. Shah, A. Richardson, J. David, K.S. Lee, M.S. Peach, E.L. Chang, G. Zada, M.A. Garcia, A. Turner, D.G. Brachman

Institutions: University of Minnesota, Brown University, Lifespan, Barrow Neurological Institute, University of California, Davis, Indiana University School of Medicine, Tampa General Hospital, East Carolina University, University of California, Los Angeles, University of Southern California, GT Medical Technologies (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Pfizer, Alnylam Pharmaceuticals, Amryt Pharma, Advanced Accelerator Applications, Servier

OpenAlex ID: W4402946523

FWCI:

Cites:

Cited by:

Related to: 10